Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 15;10(11):464.
doi: 10.3390/jcdd10110464.

The Influence of Individualized Three-Dimensional Holographic Models on Patients' Knowledge Qualified for Intervention in the Treatment of Peripheral Arterial Disease (PAD)

Affiliations

The Influence of Individualized Three-Dimensional Holographic Models on Patients' Knowledge Qualified for Intervention in the Treatment of Peripheral Arterial Disease (PAD)

Patryk Skórka et al. J Cardiovasc Dev Dis. .

Abstract

We sought to determine the role of the patient-specific, three-dimensional (3D) holographic vascular model in patient medical knowledge and its influence on obtaining a more conscious informed consent process for percutaneous balloon angioplasty (PTA). Patients with peripheral arterial disease who had been scheduled for PTA were enrolled in the study. Information regarding the primary disease, planned procedure, and informed consent was recorded in typical fashion. Subsequently, the disease and procedure details were presented to the patient, showing the patients their individual model. A patient and medical supervisor equipped with mixed reality headsets could both simultaneously manipulate the hologram using gestures. The holographic 3D model had been created on a scale of 1:1 based on computed tomography scans. The patient's knowledge was tested by the completion of a questionnaire before and after the interaction in a mixed reality environment. Seventy-nine patients manipulated arterial holograms in mixed reality head-mounted devices. Before the 3D holographic artery model interaction, the mean ± standard deviation score of the knowledge test was 2.95 ± 1.21 points. After the presentation, the score had increased to 4.39 ± 0.82, with a statistically significant difference (p = 0.0000) between the two scores. Using a Likert scale from 1 to 5, the patients had scored the use of the 3D holographic model at 3.90 points regarding its usefulness in comprehending their medical condition; at 4.04 points regarding the evaluation of the holograms as helpful in understanding the course of surgery; and rated the model at 1.99 points in reducing procedure-related stress. Using a nominal scale (know or don't know), the patients had self-assessed their knowledge of the procedure before and after the 3D model presentation, with a score of 6.29 ± 2.01 and 8.39 ± 1.54, respectively. The study group tolerated the use of head-mounted devices. Only one patient had nausea and dizziness, while four patients experienced transient eye pain. The 3D holographic arterial model aided in the understanding of patients' knowledge regarding the disease and procedure, making the informed consent process more conscious. The holograms improved the patient's self-consciousness. Mixed reality headset-related complications were rare and within acceptable rates.

Keywords: HoloLens; augmented reality; hologram; informed consent; mixed reality; patient education; percutaneous transluminal angioplasty; peripheral artery disease; surgery preparation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The hologram made available to the patient with the indication of the obstruction. Arrows indicate stenosis and obstruction of the patients arteries.
Figure 2
Figure 2
Evaluation of holograms as helpful in understanding the medical condition.
Figure 3
Figure 3
Evaluation of holograms as helpful in understanding the course of surgery.
Figure 4
Figure 4
Evaluation of holograms as helpful in stress related to the procedure.
Figure 5
Figure 5
A patient manipulates the vascular hologram using the MR headset.

Similar articles

Cited by

References

    1. Bevan G.H., White Solaru K.T. Evidence-Based Medical Management of Peripheral Artery Disease. Arterioscler. Thromb. Vasc. Biol. 2020;40:541–553. doi: 10.1161/ATVBAHA.119.312142. - DOI - PubMed
    1. Criqui M.H., Matsushita K., Aboyans V., Hess C.N., Hicks C.W., Kwan T.W., McDermott M.M., Misra S., Ujueta F. Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association. Circulation. 2021;144:e171–e191. doi: 10.1161/CIR.0000000000001005. - DOI - PMC - PubMed
    1. Golledge J. Update on the pathophysiology and medical treatment of peripheral artery disease. Nat. Rev. Cardiol. 2022;19:456–474. doi: 10.1038/s41569-021-00663-9. - DOI - PubMed
    1. Fowkes F.G.R., Rudan D., Rudan I., Aboyans V., Denenberg J.O., McDermott M.M., Norman P.E., Sampson U.K.A., Williams L.J., Mensah G.A., et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis. Lancet. 2013;382:1329–1340. doi: 10.1016/S0140-6736(13)61249-0. - DOI - PubMed
    1. Willigendael E.M., Teijink J.A.W., Bartelink M.-L., Boiten J., Moll F.L., Büller H.R., Prins M.H. Peripheral Arterial Disease: Public and Patient Awareness in the Netherlands. Eur. J. Vasc. Endovasc. Surg. 2004;27:622–628. doi: 10.1016/j.ejvs.2004.02.019. - DOI - PubMed

LinkOut - more resources